Glow+ (GHK-Cu + TB-500 + BPC-157 + KPV)
An anti-inflammatory extension of the Glow blend that adds KPV (an α-MSH fragment) to GHK-Cu, TB-500, and BPC-157, aiming to combine skin remodeling, tissue repair, and inflammation control. The four-peptide combination is untested in humans.
In plain English
'Glow+' adds KPV — a small anti-inflammatory fragment of α-MSH — to the Glow stack (GHK-Cu + TB-500 + BPC-157). The idea is to pair skin remodeling and tissue repair with KPV's anti-inflammatory effects for skin and gut. As with the base Glow blend, GHK-Cu has real human cosmetic evidence (topical), KPV has animal/in-vitro anti-inflammatory data, and TB-500 and BPC-157 are animal-only and unapproved. No study has tested this four-peptide combination, and TB-500 is WADA-banned. It is an experimental stack.
What it is
A four-peptide research blend: GHK-Cu (copper tripeptide), TB-500 (thymosin beta-4 fragment), BPC-157 (gastric pentadecapeptide), and KPV (lysine-proline-valine, the C-terminal tripeptide of α-MSH). Marketed as an enhanced skin/recovery/anti-inflammatory stack. None is FDA-approved for this use.
Mechanism (summary)
Adds KPV's anti-inflammatory activity — KPV is reported to reduce NF-κB-driven inflammatory signaling in epithelial and immune cells — to GHK-Cu's collagen/matrix remodeling and the angiogenic and cell-migration effects of BPC-157 and TB-500. The intent is to cover skin remodeling, tissue repair, and inflammation simultaneously, but this combined activity is theoretical and untested.
Why people research it
- Skin quality with reduced inflammation
- Wound and soft-tissue healing
- Gut and epithelial inflammation
- Combined cosmetic, recovery, and anti-inflammatory use
Human evidence
No human trials test this four-peptide combination. GHK-Cu has supportive human cosmetic data (topical), but KPV, TB-500, and BPC-157 have no human RCTs — KPV's anti-inflammatory evidence is animal/in-vitro, and TB-500 and BPC-157 are animal-only. The blend's claims are extrapolated from the individual components and are unproven in humans.
Animal / lab evidence
GHK-Cu supports matrix remodeling and wound healing in animal/mechanistic studies; KPV reduces experimental colitis and inflammatory signaling in mice and epithelial cells; TB-500 and BPC-157 accelerate wound and tissue healing in animals. No animal study evaluates the four peptides together.
Key studies
Each summary explains the design, what was found, and what it doesn't prove.
Human evidence for GHK on the skin, not injected and not in this stack.
Animal anti-inflammatory evidence for the KPV component; not proof for the four-peptide stack.
Animal-level support for the BPC-157 component only.
History
'Glow+' extends the Glow stack by adding KPV for its anti-inflammatory profile, marketed as a more complete skin-recovery-inflammation blend — again assembled from individual-component rationale without combination evidence.
PeptidePedia is for educational and informational purposes only. We do not sell peptides, prescribe peptides, provide medical advice, or recommend treatment. Peptides may not be approved for human use except in specific legal prescription or clinical contexts. Always consult a licensed medical professional before making health decisions.
Related peptides
A naturally occurring copper-binding tripeptide widely used in cosmetics and studied for skin remodeling and wound healing.
A synthetic fragment of thymosin beta-4 studied in animals for wound healing, cardiac repair, and tissue regeneration.
A 15-amino-acid fragment derived from a stomach-protecting protein, widely studied in rodents for gut, tendon, and ligament repair.
The C-terminal tripeptide of α-MSH studied for anti-inflammatory effects in gut and skin disease.